How Will Vitasora’s A$11M Raise Fuel Its US Remote Patient Monitoring Growth?

• A$11 million capital raise including institutional placement and director participation
• Expanded TPAC contract to a capitated risk-share model covering 15,000 patient lives
• Projected growth to 30,000 patient programs and USD 18 million ARR by H2 CY26
• Strong clinical outcomes with significant reductions in hospital readmissions